Dr. Sandra Shin

About
^{Dr. Sandra Shin}

Dr. Shin is a Professor of Pathology and Laboratory Medicine and serves as Chief of Breast Pathology.  She is also the Director of the Comprehensive Breast Pathology Consultation Service which is one of the largest of its kind providing expert consultation to pathologists, clinicians and patients across the U.S. and internationally.  For the last 15 years on the faculty, Dr. Shin has built a national and international reputation as an expert breast pathologist while running a busy clinical service and translational research program.  She is also the Director of the Pathology Residency Training Program and the Breast Pathology Fellowship Program.  Her research in breast disease has led to numerous peer-reviewed scientific publications, invited review articles and chapters in books such as Diagnostic Immunohistochemistry (4 editions), World Health Organization (WHO) Classification of Tumors of the Breast (4th edition), and Breast Pathology (2 editions). She has also served as co-guest editor of Surgical Pathology Clinics; Breast Pathology Issue (2012).  Most recently, she published a textbook entitled "A Comprehensive Guide to Core Needle Biopsies of the Breast" for which she is the sole editor.  Her scholarly activities in breast pathology have extended into national and international forums, notably her serving as a scientist grant reviewer for the Department of Defense Breast Cancer Research Program for many years and as a member of the expert breast pathology committee for the National Cancer Institute (NCI)/ The Cancer Genome Atlas (TCGA). She has given numerous invited lectures and visiting professorships on the topic of breast disease across the country as well as internationally and is a reviewer or an editorial board member for multiple medical journals. She has directed educational courses in breast pathology held at the annual meetings of College of American Pathologists (CAP) and American Society of Clinical Pathologists (ASCP).  She is funded and Co-PI of an R01 NIH/NCI grant investigating the pathophysiological role of CUL4A in mammary tumoriogenesis.